These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10885784)

  • 1. Adherence: a necessity for successful HIV combination therapy.
    Chesney MA; Ickovics J; Hecht FM; Sikipa G; Rabkin J
    AIDS; 1999; 13 Suppl A():S271-8. PubMed ID: 10885784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities.
    Nachega JB; Mills EJ; Schechter M
    Curr Opin HIV AIDS; 2010 Jan; 5(1):70-7. PubMed ID: 20046150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The recommendations of GESIDA/SEFH/PNS for improving adherence to antiretroviral treatment. AIDS Study Group of the Spanish Society of Hospital Pharmacy and the National Plan on AIDS of the Minister of Health and Consumers].
    Knobel H; Codina C; Miró JM; Carmona A; García B; Antela A; Gómez-Domingo MR; Arrizabalaga J; Iruin A; Laguna F; Jiménez I; Rubio R; Lluch A; Viciana P
    Enferm Infecc Microbiol Clin; 2000 Jan; 18(1):27-39. PubMed ID: 10721560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS in the Third World: how to stop the HIV infection?
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring HIV treatment adherence in clinical practice.
    Hecht FM
    AIDS Clin Care; 1998 Aug; 10(8):57-9. PubMed ID: 11365682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV/AIDS: a minority health issue.
    Cargill VA; Stone VE
    Med Clin North Am; 2005 Jul; 89(4):895-912. PubMed ID: 15925655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for improving patient adherence to therapy and long-term patient outcomes.
    Battaglioli-DeNero AM
    J Assoc Nurses AIDS Care; 2007; 18(1 Suppl):S17-22. PubMed ID: 17275718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adherence to antiretroviral therapy during HIV infection, a multidisciplinary approach].
    Slama L; Le Camus C; Amiel C; Pialoux G; Gharakhanian S
    Med Mal Infect; 2006 Jan; 36(1):16-26. PubMed ID: 16325363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.
    Kent DM; McGrath D; Ioannidis JP; Bennish ML
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S13-24. PubMed ID: 12822128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal drug treatment regimens for HIV depend on adherence.
    Krakovska O; Wahl LM
    J Theor Biol; 2007 Jun; 246(3):499-509. PubMed ID: 17320115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients.
    Turner BJ
    J Infect Dis; 2002 May; 185 Suppl 2():S143-51. PubMed ID: 12001036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiatives to promote adherence in HIV-infected patients.
    Reynolds NR
    AIDS Read; 1999; 9(1):53-6. PubMed ID: 12728885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [AIDS treatment in Africa: the risk of antiretroviral resistance].
    Hamers RL; Schuurman R; van Vugt M; Derdelinckx I; Rinke de Wit TF
    Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2666-71. PubMed ID: 18179083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High antiretroviral drug adherence key in effort to avoid drug resistance. New study highlights its importance.
    AIDS Alert; 2005 Mar; 20(3):25, 27-8. PubMed ID: 15789470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
    Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
    Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting and monitoring antiretroviral adherence.
    Gross R
    LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of approaches to enhancing of patient adherence to antivirus therapy in the treatment of human immunodeficiency virus infection].
    Beliaeva VV; Kravchenko AV; Pokrovskiĭ VV
    Ter Arkh; 2003; 75(11):36-8. PubMed ID: 14708439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.